BioPlus Acquisition Corp. (NASDAQ:BIOS) currently has a daily average trading volume of 194.24K but it saw 1495028 shares traded on Thursday. With a market cap of 308.49M USD, stock’s current market price of $10.52 came rising about 0.05 while comparing to the previous closing price of $10.52. In past 52 weeks, the stock remained buoying in the range of price level as high as $10.53 and as low as $9.89. In the recent trading on the day, stock has struck highest price mark of $10.525 while lowest mark touched by it was $10.51.
Unlock the Hottest Top 10 Penny Stocks Today! Discover Now
Dive into the world of lucrative penny stocks with MarketClub's groundbreaking "Smart Scan" technology! Get an instant snapshot of the top 50 high volume stocks with a clear direction and outstanding liquidity - in other words, the strongest trending. To unlock this exclusive list, simply provide your first name, last name, and email for instant access.
Gain Access to Top 10 Penny Stocks Now!.
Sponsored
Taking a look at 20-day trading activity of BioPlus Acquisition Corp. (BIOS) gives us an average price of $10.50, while its current price level is -0.05% below from 52-week high level whereas it is 6.42% above from lowest level seen by the stock during that period. Simple moving average of 50 days or SMA-50 of the stock’s closing price is $10.46 while that of 200 days or SMA-200 reads an average of $10.19. A closer look into the stock’s movement over the week reveals that its volatility is standing at 0.12% during that period while stretching the period over a month that decreases to 0.11%. It is also necessary to take a look into other indicators of a stock too, to get a better idea about its price movement. And in doing so, we find stock’s 14-day relative strength index (RSI) standing at 67.28 which implies that the stock is in neutral territory.
Data by FactSet Research shows that 0 analysts have issued their ratings for the stock. 0 of them are in opinions that stock is a Sell, while 0 are advising it as an Overweight. 0 analysts suggested the investors to Buy the stock while 0 advised them to Hold. Recommendations by all of those brokerages imply a consensus rating of – for the stock and that issued by Wall Street to investors is Strong Buy.
Over the week, BIOS’s stock price is moving 0.14% up while it is 0.62% when we observe its performance for the past one month. Year-to-date it is 2.98% up and over the past year.
The latest quarterly earnings report issued by the company was for quarter ended 12/30/2019, when its quarterly earnings per share (EPS) of -$0.09 beaten by the consensus estimate of -$0.06 for the same. For BIOS, analysts are forecasting an EPS-growth rate of 63.30% for current year and estimate for EPS growth in next year is 277.80%. In next quarter, company is expected to be making quarterly sales of $713.19 million as analysts are expecting the sales for current fiscal year at $2.86 billion and seeing the company making $3.03 billion in sales next year. Moreover, analysts are in estimates of $684.51 million for current-quarter revenue.
Currently, BioPlus Acquisition Corp.’s total number of outstanding shares is 29.31M. It has a price to earnings ratio (P/E ratio) of 154.78 while having a 32.89 of forward P/E ratio.
